Thirty evaluable patients with advanced carcinoma of the pancreas received treatment with either daily x 5 bolus or continuous infusion x 5 days recombinant γ-interferon. No responses were noted. Major toxicities included fever, hypotension, and flu-like symptoms. γ-Interferon does not appear to be an active single agent for patients with advanced pancreatic cancer.
|Number of pages||4|
|Journal||Journal of Biological Response Modifiers|
|State||Published - Dec 1 1990|
- Pancreatic cancer
ASJC Scopus subject areas
- Cancer Research